MAPT and Alzheimer disease: Because prior reports showed pronounced differences in pathological burden between male and female 3xTg-AD mice [87, 88], we began the current study by evaluating sex differences among all protein measures: cytokines, MAPK phospho-proteins, glial markers, phosphorylated and total tau, and Aβ40/42.